SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

about

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

Item

http://www.wikidata.org/entity/Q47976126

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

@en

SEOM clinical guideline of diagnosis and management of low-grade glioma

@nl

type

Item

label

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

@en

SEOM clinical guideline of diagnosis and management of low-grade glioma

@nl

prefLabel

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

@en

SEOM clinical guideline of diagnosis and management of low-grade glioma

@nl

P1476

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

@en

P2093

A Hernández Laín

http://www.w3.org/2001/XMLSchema#string

E Vicente

http://www.w3.org/2001/XMLSchema#string

J Fuster

http://www.w3.org/2001/XMLSchema#string

J Muñoz Langa

http://www.w3.org/2001/XMLSchema#string

M Vidal Denis

http://www.w3.org/2001/XMLSchema#string

M Á Arráez

http://www.w3.org/2001/XMLSchema#string

V Rodríguez González

http://www.w3.org/2001/XMLSchema#string

Ó Gallego

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Potential of MR spectroscopy for assessment of glioma grading.

Advances in the Surgical Management of Low-Grade Glioma

The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.

IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival.

P2888

s12094-017-1790-3

P304

3-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1790-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gaspar Reynés

J M Sepúlveda-Sánchez

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29124520

http://www.w3.org/2001/XMLSchema#string

P932

5785601

http://www.w3.org/2001/XMLSchema#string